Treatment for and Related Conditions Associated with Rhinitis, Asthma, Colds, Coughs

This review will highlight drugs in the cough/cold treatment area where the staff at IHC has had experience in designing, conducting, analyzing and reporting the clinical results. Taking just one company’s products for example – you can prepare to combat a competitor’s claims for Comtrex®, Theraflu®, even Buckley’s®, Delsym®, Otrivin® or pursue switching another of
Read more
No Comments

Diarrhea, Constipation: Treatment & Related Conditions

This review will highlight IHC’s expertise as you consider extending the claims of your drugs used in treating these and related clinical conditions.  Our staff has had direct experience designing, conducting and analyzing clinical studies evaluating these drugs and other drugs that are in competition with you. Condition or Disease Clinical Experience with Drugs used
Read more
No Comments

Heartburn Treatment & Prevention

This review will highlight items to consider before you implement you clinical program to evaluate a new drug in this area, switch a prescription drug or extend the claims of an already existing drug. Our staff has had more experience in this therapeutic area than virtually any other group designing the clinical programs, identifying the
Read more
No Comments

Clinical Expertise with Cardiovascular Drugs

… And The Disorders They Treat IHC has had extensive experience and expertise designing, conducting and analyzing drugs used in the treatment of various cardiovascular disorders.  We have presented below some details of the studies we conducted and managed with the goal to show the complexity of these programs and through the success of these
Read more
No Comments

Risk-Based Approach to Monitoring & Adaptive Clinical Research

We are in the forefront of following the new Clinical Research Guidelines and trends from the FDA. Whether its structuring the clinical program to enable a risk-based approach to monitoring or designing the program to assess product efficacy (and safety) at prospective time points thereby adapting the study data collection plan to maximize the ‘interim’
Read more
No Comments